Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation

Yasuo Mori; Goichi Yoshimoto; Jun Ichiro Yuda; Masayasu Hayashi; Jun Odawara; Takuro Kuriyama; Takeshi Sugio; Kohta Miyawaki; Kenjiro Kamezaki; Koji Kato; Katsuto Takenaka; Hiromi Iwasaki; Takahiro Maeda; Toshihiro Miyamoto; Koichi Akashi

doi:10.1080/10428194.2018.1466295

Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation

Yasuo Mori, Goichi Yoshimoto, Jun Ichiro Yuda, Masayasu Hayashi, Jun Odawara, Takuro Kuriyama, Takeshi Sugio, Kohta Miyawaki, Kenjiro Kamezaki, Koji Kato, Katsuto Takenaka, Hiromi Iwasaki, Takahiro Maeda, Toshihiro Miyamoto, Koichi Akashi

研究成果: ジャーナルへの寄稿 › レター › 査読

2 被引用数 (Scopus)

本文言語	英語
ページ（範囲）	271-273
ページ数	3
ジャーナル	Leukemia and Lymphoma
巻	60
号	1
DOI	https://doi.org/10.1080/10428194.2018.1466295
出版ステータス	出版済み - 1月 2 2019

!!!All Science Journal Classification (ASJC) codes

血液学
腫瘍学
癌研究

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1080/10428194.2018.1466295

他のファイルとリンク

引用スタイル

Mori, Y., Yoshimoto, G., Yuda, J. I., Hayashi, M., Odawara, J., Kuriyama, T., Sugio, T., Miyawaki, K., Kamezaki, K., Kato, K., Takenaka, K., Iwasaki, H., Maeda, T., Miyamoto, T., & Akashi, K. (2019). Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation. Leukemia and Lymphoma, 60(1), 271-273. https://doi.org/10.1080/10428194.2018.1466295

Mori, Y, Yoshimoto, G, Yuda, JI, Hayashi, M, Odawara, J, Kuriyama, T, Sugio, T, Miyawaki, K, Kamezaki, K, Kato, K, Takenaka, K, Iwasaki, H, Maeda, T, Miyamoto, T & Akashi, K 2019, 'Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation', Leukemia and Lymphoma, vol. 60, no. 1, pp. 271-273. https://doi.org/10.1080/10428194.2018.1466295

@article{27fde151093c47a78ea3e1ec606fe935,

title = "Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation",

author = "Yasuo Mori and Goichi Yoshimoto and Yuda, {Jun Ichiro} and Masayasu Hayashi and Jun Odawara and Takuro Kuriyama and Takeshi Sugio and Kohta Miyawaki and Kenjiro Kamezaki and Koji Kato and Katsuto Takenaka and Hiromi Iwasaki and Takahiro Maeda and Toshihiro Miyamoto and Koichi Akashi",

year = "2019",

month = jan,

day = "2",

doi = "10.1080/10428194.2018.1466295",

language = "English",

volume = "60",

pages = "271--273",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "1",

}

TY - JOUR

T1 - Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation

AU - Mori, Yasuo

AU - Yoshimoto, Goichi

AU - Yuda, Jun Ichiro

AU - Hayashi, Masayasu

AU - Odawara, Jun

AU - Kuriyama, Takuro

AU - Sugio, Takeshi

AU - Miyawaki, Kohta

AU - Kamezaki, Kenjiro

AU - Kato, Koji

AU - Takenaka, Katsuto

AU - Iwasaki, Hiromi

AU - Maeda, Takahiro

AU - Miyamoto, Toshihiro

AU - Akashi, Koichi

PY - 2019/1/2

Y1 - 2019/1/2

UR - http://www.scopus.com/inward/record.url?scp=85046676639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046676639&partnerID=8YFLogxK

U2 - 10.1080/10428194.2018.1466295

DO - 10.1080/10428194.2018.1466295

M3 - Letter

C2 - 29741437

AN - SCOPUS:85046676639

SN - 1042-8194

VL - 60

SP - 271

EP - 273

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 1

ER -